Appeals Court Urged to Overturn Dismissal of Zostavax Shingles Lawsuits
More than 1,00 plaintiffs whose Zostavax shingles injury lawsuits were dismissed last year are appealing the decision to the Third Circuit to have their cases reinstated.
More than 1,00 plaintiffs whose Zostavax shingles injury lawsuits were dismissed last year are appealing the decision to the Third Circuit to have their cases reinstated.
A federal judge has dismissed more than 1,100 Zostavax lawsuits claiming the vaccine caused recipients to develop shingles, which it was supposed to prevent.
The CDC says it approves of the use of Shingrix in immunocompromised adults, which was contraindicated for the competing shingles live virus vaccine, Zostavax.
A federal judge has denied a motion by Merck to dismiss Zostavax shingles vaccine lawsuits which claimed the cases were preempted by federal law.
The Shingrix vaccine appears to be linked to a small, but statistically significant, increased risk og Guillain-Barre Syndrome, according to the findings of a study which led to new label…
A Zostavax lawsuit claims a woman suffered shingles after receiving the vaccine, which is supposed to prevent the condition.
A "science Day" has been scheduled for late September, to help the Court understand the science involved in claims the Zostavax vaccine causes shingles and other health problems instead of…
A federal judge has rejected an effort by Merck to have a Zostavax shingles lawsuit thrown out on statute of limitations grounds.
A federal judge has scheduled the first Zostavax lawsuit for January 2022, pushing it back from a previous November start date.
The Shingrix vaccine, used to prevent shingles, may increase the risk of Guillain-Barre Syndrome, which can cause muscle weakness and paralysis, the FDA warns.